Document Detail


Chemoresistance testing of human ovarian cancer cells and its in vitro model.
MedLine Citation:
PMID:  20736059     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ovarian carcinoma represents the most common cause of death from gynecological malignancies in Europe and North America, being the third most frequent and the first as to the mortality. The standard chemotherapeutical regimen for ovarian cancer involves the administration of platinum derivate (carboplatin, cisplatin), in advanced stage is platinum derivate combined with paclitaxel. Introducing chemoresistance testing of ovarian tumour cells may help to choose optimal chemotherapeutic drug and customize the individual chemotherapeutical regimens in patients. One of approaches of individualization of chemotherapy is in vitro chemosensitivity testing. In our study, we evaluated the cytotoxic effects of selected chemotherapeutics in cells isolated from ovarian tumours and ascites of individual patients. Panel of chemotherapeutics used in the study included cisplatin, paclitaxel, carboplatin, topotecan, gemcitabine and etoposide and their effects on cell viability were determined by the MTT assay. In the total number of 32 clinical samples of tumour and ascites cells, the highest sensitivity showed cells to topotecan, sensitivity to cisplatin was higher than to carboplatin and paclitaxel used in clinical practice showed most often only the marginal reactivity. Resistance to carboplatin and most of the time to gemcitabine and etoposide was commonly present. When the same test on cells that have been frozen for several weeks was repeated it was found that in 20 cases chemosensitivity increased while in 18 cases decreased. In remaining cases there was no change in reactivity to cytostatics. Moreover, chemosensitivity of cells isolated from solid tumour and ascites from the same patient did not show any significant difference with exaption of paclitaxel.
Authors:
K Brigulová; M Cervinka; J Tošner; I Sedláková
Related Documents :
6115499 - Immunocytochemistry and electron microscopy of an argentaffin endocrine tumour of the p...
6291299 - Specific binding sites for epidermal growth factor and its effect on human chorionic go...
7599789 - Expression of the glycolipid globotriaosylceramide (gb3) in testicular carcinoma in situ.
8102179 - Expression of proliferating cell nuclear antigen (pcna) in dysplasia of the bronchial e...
1692339 - The behaviour of human oral squamous cell carcinoma in cell culture.
9463579 - Peripheral primitive neuroectodermal tumour with ganglioneuroma-like areas arising in t...
23221619 - Inhibition of class i histone deacetylases in non-small cell lung cancer by honokiol le...
8171319 - Genetic control of programmed cell death in drosophila.
2325589 - The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-08-22
Journal Detail:
Title:  Toxicology in vitro : an international journal published in association with BIBRA     Volume:  24     ISSN:  1879-3177     ISO Abbreviation:  Toxicol In Vitro     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-24     Completed Date:  2011-01-10     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8712158     Medline TA:  Toxicol In Vitro     Country:  England    
Other Details:
Languages:  eng     Pagination:  2108-15     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Department of Medical Biology and Genetics Faculty of Medicine in Hradec Kralove, Charles University in Prague, Czech Republic. brigulovak@lfhk.cuni.cz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / toxicity
Carboplatin / toxicity
Carcinoma / drug therapy*
Cell Line, Tumor
Cisplatin / toxicity
Deoxycytidine / analogs & derivatives,  toxicity
Drug Resistance, Neoplasm*
Drug Screening Assays, Antitumor
Etoposide / toxicity
Female
Humans
Models, Biological
Ovarian Neoplasms / drug therapy*
Paclitaxel / toxicity
Topotecan / toxicity
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 123948-87-8/Topotecan; 15663-27-1/Cisplatin; 33069-62-4/Paclitaxel; 33419-42-0/Etoposide; 41575-94-4/Carboplatin; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-androgenic activities of environmental pesticides in the MDA-kb2 reporter cell line.
Next Document:  Genome-wide analysis of expression modes and DNA methylation status at sense-antisense transcript lo...